EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 123 filers reported holding EXELIXIS INC in Q1 2015. The put-call ratio across all filers is 1.82 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $149,000 | +16.4% | 10,000 | 0.0% | 0.04% | +22.9% |
| Q3 2016 | $128,000 | +64.1% | 10,000 | 0.0% | 0.04% | +75.0% |
| Q2 2016 | $78,000 | +95.0% | 10,000 | 0.0% | 0.02% | +100.0% |
| Q1 2016 | $40,000 | -32.2% | 10,000 | -4.1% | 0.01% | -28.6% |
| Q4 2015 | $59,000 | -6.3% | 10,430 | -7.1% | 0.01% | -22.2% |
| Q3 2015 | $63,000 | +50.0% | 11,230 | 0.0% | 0.02% | +50.0% |
| Q2 2015 | $42,000 | +44.8% | 11,230 | 0.0% | 0.01% | +50.0% |
| Q1 2015 | $29,000 | +81.2% | 11,230 | 0.0% | 0.01% | +100.0% |
| Q4 2014 | $16,000 | -5.9% | 11,230 | 0.0% | 0.00% | -20.0% |
| Q3 2014 | $17,000 | -58.5% | 11,230 | -8.2% | 0.01% | -54.5% |
| Q2 2014 | $41,000 | -4.7% | 12,230 | 0.0% | 0.01% | -8.3% |
| Q1 2014 | $43,000 | -42.7% | 12,230 | 0.0% | 0.01% | -45.5% |
| Q4 2013 | $75,000 | +5.6% | 12,230 | 0.0% | 0.02% | 0.0% |
| Q3 2013 | $71,000 | +26.8% | 12,230 | 0.0% | 0.02% | +29.4% |
| Q2 2013 | $56,000 | – | 12,230 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 16,484,638 | $501,133,000 | 64.50% |
| Matrix Capital Management Company, LP | 10,000,000 | $304,000,000 | 10.86% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 410,334 | $12,470,000 | 4.40% |
| Rhenman & Partners Asset Management AB | 756,214 | $22,989,000 | 3.11% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 703,049 | $21,372,000 | 1.57% |
| Virtus ETF Advisers LLC | 36,522 | $1,110,000 | 1.39% |
| PURA VIDA INVESTMENTS, LLC | 80,000 | $2,432,000 | 1.02% |
| Crawford Lake Capital Management, LLC | 129,300 | $3,931,000 | 0.93% |
| SMITH ASSET MANAGEMENT GROUP LP | 865,880 | $26,323,000 | 0.83% |
| Crawford Lake Capital Management, LLC | 113,311 | $3,445,000 | 0.81% |